AIIMS Delhi to start Covaxin trials on children in few days

AIIMS Delhi to start Covaxin trials on children in few days
ANI
03 Jun 2021, 21:55 GMT+10
By Shalini BhardwajNew Delhi [India], June 3 (ANI): After All India Institute of Medical Sciences (AIIMS), Patna, now AIIMS Delhi is also planning to start the Paediatric clinical trials of the indigenous Bharat Biotech's COVID-19 vaccine "Covaxin" in few days, sources said on Thursday.
The paediatric trials for Covaxin started in AIIMS Patna on Tuesday after Bharat Biotech's COVID-19 vaccine received the Drugs Controller General of India (DCGI) nod to conduct clinical trials on children on May 11.
"AIIMS Patna has started trials in the age of 12-18 years, we have started clinical trials of Covaxin after registration for this age only," said Dr Prabhat Kumar Singh, Director, AIIMS, Patna.

Related Keywords

Patna , Bihar , India , Delhi , Bharat , Prabhat Kumar Singh , Serum Institute Covishield , Member Health , India Institute Of Medical Sciences , Shalini Bhardwajnew Delhi , After All India Institute , Medical Sciences , Bharat Biotech , Drugs Controller General , Niti Aayog , Serum Institute , Russia News , Controller General , Age Group , Aiims Delhi , Covid , The Paediatric , Paediatric , Controller , Biotech , பாட்னா , பிஹார் , இந்தியா , டெல்ஹி , பாரத் , பிரபத் குமார் சிங் , உறுப்பினர் ஆரோக்கியம் , இந்தியா நிறுவனம் ஆஃப் மருத்துவ அறிவியல் , மருத்துவ அறிவியல் , பாரத் பயோடெக் , மருந்துகள் கட்டுப்படுத்தி ஜநரல் , நீதி ஆயோக் , சீரம் நிறுவனம் , ரஷ்யா செய்தி , கே குழு , விட் , இோதேச் ,